Cited by

• Modeling Benefits, Costs, and Affordability of a Novel Gene Therapy in Hemophilia A.

  Ten Ham RMT, Walker SM, Soares MO, Frederix GWJ, Leebeek FWG, Fischer K, Coppens M, Palmer SJ. Ten Ham RMT, et al. Hemasphere. 2022 Jan 28;6(2):e679. doi: 10.1097/HS9.0000000000000679. eCollection 2022 Feb. Hemasphere. 2022. PMID: 35141470 Free PMC article.
• Analytical variation in factor VIII one-stage and chromogenic assays: Experiences from the ECAT external quality assessment programme.

  van Moort I, Meijer P, Priem-Visser D, van Gammeren AJ, Péquériaux NCV, Leebeek FWG, Cnossen MH, de Maat MPM. van Moort I, et al. Haemophilia. 2019 Jan;25(1):162-169. doi: 10.1111/hae.13643. Epub 2018 Nov 29. Haemophilia. 2019. PMID: 30488994 Free PMC article.
• Tachyphylaxis and reproducibility of desmopressin response in perioperative persons with nonsevere hemophilia A: implications for clinical practice.

  Romano LGR, Schütte LM, van Hest RM, Meijer K, Laros-van Gorkom BAP, Nieuwenhuizen L, Eikenboom J, Heubel-Moenen FCJI, Uitslager N, Coppens M, Fijnvandraat K, Driessens MHE, Polinder S, Cnossen MH, Leebeek FWG, Mathôt RAA, Kruip MJHA; DAVID and SYMPHONY Consortium. Romano LGR, et al. Res Pract Thromb Haemost. 2024 Mar 5;8(3):102367. doi: 10.1016/j.rpth.2024.102367. eCollection 2024 Mar. Res Pract Thromb Haemost. 2024. PMID: 38660455 Free PMC article.
• Diabetes mellitus and acquired haemophilia: new association?

  Tavares Bello C, Vasylenko Y, Esteves J, Vasconcelos CA. Tavares Bello C, et al. BMJ Case Rep. 2017 Apr 24;2017:bcr2017219807. doi: 10.1136/bcr-2017-219807. BMJ Case Rep. 2017. PMID: 28438758 Free PMC article.
• Multicenter performance evaluation and reference range determination of a new one-stage factor VIII assay.

  Lowe AE, Jones R, Kitchen S, Geisen U, Rozsnyai G, Jilma P, Quehenberger P. Lowe AE, et al. J Clin Lab Anal. 2022 Apr;36(4):e24294. doi: 10.1002/jcla.24294. Epub 2022 Mar 11. J Clin Lab Anal. 2022. PMID: 35274775 Free PMC article.